Treatment for chronic elbow and foot pain using a minimally invasive procedure
Transcatheter Arterial Embolization for Relief of Chronic Musculoskeletal Elbow and Foot Plantar Pain Refractory to Conservative Treatment
NA · Chung-Ang University Hosptial, Chung-Ang University College of Medicine · NCT06523114
This study is testing a new, less invasive procedure to see if it can help people with chronic elbow or foot pain that hasn't improved with other treatments.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 13 (estimated) |
| Ages | 19 Years to 85 Years |
| Sex | All |
| Sponsor | Chung-Ang University Hosptial, Chung-Ang University College of Medicine (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06523114 on ClinicalTrials.gov |
What this trial studies
This prospective single-arm study aims to evaluate the effectiveness and safety of transcatheter arterial embolization (TAE) in patients suffering from moderate to severe chronic elbow or foot plantar pain due to conditions like lateral epicondylitis or plantar fasciitis that have not responded to conservative treatments. Participants will undergo TAE after providing informed consent, and the procedure will involve using imipenem as an embolic material to target the painful area. Follow-up assessments will be conducted at 1, 3, 6, and 12 months post-procedure to measure changes in pain levels and range of motion. The study is conducted at Chung-Ang University Hospital in Seoul.
Who should consider this trial
Good fit: Ideal candidates are individuals with chronic elbow or foot pain lasting more than 6 months who have not benefited from conservative therapies.
Not a fit: Patients who are pregnant, breastfeeding, have local infections, or bleeding disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide significant pain relief and improved function for patients with chronic elbow and foot pain.
How similar studies have performed: While the use of transcatheter arterial embolization is a novel approach for these specific conditions, similar techniques have shown promise in other pain management studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who voluntarily signed a written consent form after receiving an explanation of the purpose, method, and effects of this clinical trial * Patients who have had pain in the relevant area for more than 6 months and have a history of receiving physical therapy, analgesic anti-inflammatory medication, or local injection treatment * Patients in whom hypervascularization was confirmed in the relevant area through imaging results (US, CT, MRI) evaluating the cause of pain. Exclusion Criteria: * Patients are pregnant or breastfeeding * Local infection in the painful area * Patients have a bleeding disease
Where this trial is running
Seoul
- Chung-Ang University Hospital — Seoul, Korea, Republic of (RECRUITING)
Study contacts
- Study coordinator: Woosun Choi, MD. Ph D.
- Email: radiochoi527@cauhs.or.kr
- Phone: +82-10-2223-5073
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Elbow Tendinitis, Elbow Tendinopathy, Epicondylitis of the Elbow, Epicondylitis, Lateral, Plantar Fascitis, Embolization